Article

COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study

2024-01-02

Abstract excerpt

<title>Abstract</title> <p>Patients with chronic lymphocytic leukemia (CLL) are at high risk of developing severe COVID-19. The present study was undertaken to elucidate COVID-19 related morbidity and mortality in CLL patients treated with venetoclax. We present a single-center study of 108 patients with small lymphocytic lymphoma or CLL treated with venetoclax. Primary outcome was 30-day COVID-19 mortality. Seco...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f7b05f36-950e-5f58-8f0d-713df8f1a262
DOI: 10.21203/rs.3.rs-3750075/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort studyDOI 10.21203/rs.3.rs-3750075/v1Read

Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.Semantic proximity Read

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraSemantic proximity Read

Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.Semantic proximity Read

Clinical Characteristics of SARS-COV-2 Omicron Variant in Acute Myeloid Leukemia and Acute Lymphocytic Leukemia Patients: A Multi-Center Retrospective StudySemantic proximity Read

Patients with CLL have similar high risk of death upon the omicron variant of COVID-19 as previously during the pandemicSemantic proximity Read

Risk Factors for In-hospital Progression of Ordinary COVID-19 in Wuhan, China: A Retrospective Cohort StudySemantic proximity Read

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read

Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.Semantic proximity Read

Chronic lymphocytic leukemia treatment algorithm 2022.Semantic proximity Read

Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results.Semantic proximity Read

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective studySemantic proximity Read

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upSemantic proximity Read